Skip to main content
logo
Camp4 Therapeutics Corporation (CAMP)
NASDAQ: CAMP · Real-Time Price · USD
4.320
-0.160 (-3.57%)
At close: Aug 24, 2026, 4:00 PM EDT
4.400
+0.080 (1.85%)
After-hours: Aug 24, 2026, 7:30 PM EDT

Camp4 Therapeutics Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Revenue
4.223.50.650.35-
Revenue Growth
40.21%436.50%86.29%--
Cost of Revenue
38.6938.238.8240.6234.1
Gross Profit
-34.47-34.7-38.17-40.27-34.1
Selling, General & Admin
17.9117.3614.9211.6110.23
Research & Development
----0.68
Operating Expenses
17.9117.3614.9211.6110.91
Operating Income
-52.38-52.06-53.09-51.88-45
Interest Expense
----0.03-
Interest & Investment Income
2.852.171.332.810.9
Other Non Operating Income (Expenses)
-57.22-30.02-0.03-0.19-0.1
EBT Excluding Unusual Items
-106.75-79.91-51.79-49.29-44.19
Asset Writedown
-0.49-0.49---
Pretax Income
-107.24-80.4-51.79-49.29-44.19
Net Income
-107.24-80.4-51.79-49.29-44.19
Net Income to Common
-107.24-80.4-51.79-49.29-44.19
Net Income Growth
-----
Shares Outstanding (Basic)
4930500
Shares Outstanding (Diluted)
4930500
Shares Change
239.08%547.76%1087.44%26.47%-
EPS (Basic)
-2.18-2.65-11.04-124.79-141.51
EPS (Diluted)
-2.18-2.65-11.04-124.79-141.51
EPS Growth
-----

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22
Free Cash Flow
-28.72-29.83-46-44.83-42.57
Free Cash Flow Per Share
-0.58-0.98-9.81-113.51-136.31
Operating Margin
-1242.51%-1488.31%-8142.33%-14822.57%-
Profit Margin
-2543.74%-2298.54%-7943.40%-14083.14%-
Free Cash Flow Margin
-681.21%-852.83%-7055.67%-12809.43%-
EBITDA
-50.56-50.42-51.39-50.2-44.12
D&A For EBITDA
1.821.641.71.680.88
EBIT
-52.38-52.06-53.09-51.88-45
SEC Filings: 10-K · 10-Q